Trigger for acute change in plaque morphology is unknown, but may be related to increased expression of MMP
High Risk Features:
90 - 94% Stenosis
Irregular / ulcerated plaque
Investigations
Duplex USS - 94% sensitive and specific for detecting severe stenoses
Flow ratio (velocity) estimates stenosis
MRA
CTA
Angiography = Gold standard – 1 - 4% risk of stroke
Absolute indications
Technically inadequate duplex
Lesion beyond carotid bulb
Anatomic variants
Relative
Unusually high bifurcation
Recurrent stenosis
Severe fixed neurological deficit
Other complications
Allergy to contrast < 2%
Contrast-induced nephropathy
Puncture site problem
Screening
Asymptomatic pts > 65yrs with ≥ 3 cardiovascular risk factors but US Preventative Services Task Force (USPSTF) guidelines say that routine screening is not indicated as benefits do not outweigh risks
Symptomatic PVD (but not AAA alone)
Radiotherapy (≥ 45Gy) for head & neck Ca – screen 10 yrs post-Rx
Post-Carotid Endarterectomy – can screen contralateral side, esp. if baseline stenosis ≥50%
Renal ischaemic events
Not necessarily if just renal artery stenosis
Management
Carotid Endarterectomy
Oblique anterior SCM incision
CCA/ICA/ECA exposed
Facial vein transected, lateral retraction of IJV
Dissection up to hypoglossal nerve (may need to ligate muscular branches to SCM from ECA & ligate small branches to IJV)
CCA/ICA/ECA dissected circumferentially & looped
Systemic heparinisation (100U/kg)
Sequential clamping ICA, CCA, ECA
Monitor ICA stump pressures
Anterolateral arteriotomy – common to ICA
(Shunt – Javid/ Pruitt)
Elevation of plaque with tacking sutures at distal end
Primary or vein/gortex patch closure
Flush arteriotomy
Remove clamps (ECA/CCA/ICA)
Skin closure
Indicated for:
Symptomatic lesions > 70%
Asymptomatic lesions > 60% if operative risk is < 3% & life expectancy is > 5%
Decreases stroke risk for symptomatic patients with > 70% stenosis from 26% → 9% at 2 years
Some benefit in symptomatic patients with 50-69% stenosis: 22% → 15.7% risk of stroke at 5 yrs
NNT= 6 to prevent one stroke / death
Asymptomatic lesion
Small risk reduction for asymptomatic pts with > 70% stenosis (12% → 6%)
ACAS North America & the European ACST
NNT=19 to prevent one stroke / death (*)
Overall: ≈ 30% risk reduction for stroke over three years (Cochrane 2005)
Semi-acute OT – after small TIA / stroke
After small stroke in pts ASA I/II: surgery within 2-4 weeks → perioperative stroke risk = 2-7%;
but if big stroke / unstable neurological deficit / ASA III or IV → ↑ perioperative stroke risk therefore best to delay surgery by ≈ 6 weeks
General Points
Thromboendarterectomy cannot be performed when the ICA completely occluded
Coexistent coronary disease treated first
Most strokes during cardiac procedure are from atheroma in aortic arch, not low flow through carotids
Stroke risk within 30 days = 3%; death rate < 1%
May be higher if contralateral occlusion
Possible with regional anaesthesia (superficial & deep cervical plexus block – at posterior aspect of SCM) + awake neurological monitoring with selective shunting (only use intra-op shunt in the people who start to develop neurological Sx after cross-clamping)
Trial also not useful because no protection device was used
SAPPHIRE = Stenting and angioplasty with protection in pts at high risk for endarterectomy: >300pts; 2/3 were asymptomatic with >80% stenosis
Similar results for high risk pts undergoing stenting vs endarterectomy – for death & stroke & for stroke rates at 3yrs
Fewer immediate peri-op complications after stenting
Results improving (esp. since the intro of cerebral protection devices)
Useful for lesions that recur after surgical treatment
CREST study: similar results as surgery; higher morbidity in pts >80yrs
Carotid Artery Bypass
Rarely used for: long segment atherosclerosis, aneurysm disease, traumatic arterial disruption, re-stenosis after endarterectomy, as part of neck resections
Complications
CVA/ Death
Haemorrhage
Nerve damage
Hypoglossal, Ansa Cervicalis, Carotid Sinus nerve
Marginal Mandibular
Vagus, Recurrent Laryngeal, External Laryngeal
Great Auricular, Transverse cervical, Spinal Accessory
Glossopharyngeal, Sympathetic
Prognosis / Natural Hx:
Stroke risk in symptomatic after 2 yrs → 25-30% (↓ to 2-10% with surgery)
Stroke risk lower (≈ 20%) in pts with amaurosis fugax
After Bypass:
Peri-op stroke & mortality rate = 7.1%
5-yr graft patency rate: 74% for PTFE & 92% for autogenous vein grafts
Risk factors for peri-op stroke (& likely to need intra-op shunting)